View All Key Stats
BIIB Key Stats
| Income Statement | |
| Revenue (TTM) | 11.53B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 15.97 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 3.480B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 86.32% |
| Profit Margin (Quarterly) | 26.60% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 59.35B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 5.287 |
| PE Ratio (TTM) | 17.52 |
| Price to Book Value | 5.170 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.5675 |
| Free Cash Flow (Quarterly) | -830.00M |
| Return on Equity (TTM) | 30.27% |
View All BIIB News
BIIB News
-
WireHeadlineTime (ET)
-
Yahoo06/26 18:38
-
Yahoo06/23 09:54
-
MT Newswires06/23 09:04
-
MT Newswires06/23 08:16
-
SA Breaking News06/23 08:12
-
Business Wire06/23 07:55
-
Yahoo06/22 16:53
-
SA Breaking News06/22 12:27
-
Yahoo06/22 06:48
-
SA Breaking News06/21 19:22
View All Events
BIIB Events
| Date | Type | Description |
|---|---|---|
| 06/07/2017 | Misc | Biogen Inc Annual General Meeting in 2016 |
| 04/25/2017 08:30 EDT | Misc | Biogen Inc First Quarter Earnings Conference Call in 2017 |
| 04/25/2017 | Earnings | Biogen Inc First Quarter Earnings in 2017 Release |
| 02/02/2017 | Spinoffs | Ratio: 1085657:1000000 |
| 01/26/2017 08:30 EST | Misc | Biogen Inc Fourth Quarter Earnings Conference Call in 2016 |
| 01/26/2017 | Earnings | Biogen Inc Fourth Quarter Earnings in 2016 Release |
| 01/06/2017 | Misc | Biogen Spin-off Bioverativ Investor Day Webcast |
| 10/26/2016 08:30 EDT | Misc | Biogen Inc Third Quarter Earnings Conference Call in 2016 |
| 10/26/2016 | Earnings | Biogen Inc Third Quarter Earnings in 2016 Release |
| 07/21/2016 08:30 EDT | Misc | Biogen Inc Second Quarter Earnings Conference Call in 2016 |
BIIB Fundamentals
Income Statement View Statement
BIIB Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
BIIB One Page Reports
- One Page Report Download
BIIB Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 279.81 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.biogen.com
- Investor Relations URL: https://www.biogen.com/en_us/investors.html
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Apr. 25, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
BIIB Comparables
EditBIIB Excel Add-In Codes
- Name: =YCI("BIIB","name")
- Description: =YCI("BIIB","description")
- Sector: =YCI("BIIB","sector")
- Industry: =YCI("BIIB","industry")
- Est. Current Fiscal Year End: =YCI("BIIB","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other BIIB Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BIIB Tweets Stocktwits
Advertisement
